UBS Group’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-138,614
| Closed | -$1.7M | – | 9948 |
|
2022
Q4 | $1.7M | Buy |
138,614
+115,690
| +505% | +$1.42M | ﹤0.01% | 2689 |
|
2022
Q3 | $753K | Buy |
22,924
+22,052
| +2,529% | +$724K | ﹤0.01% | 3057 |
|
2022
Q2 | $16K | Sell |
872
-1,283
| -60% | -$23.5K | ﹤0.01% | 6210 |
|
2022
Q1 | $38K | Buy |
+2,155
| New | +$38K | ﹤0.01% | 5744 |
|